Drug
Eos884448
Eos884448: highest development phase Phase 1, developed by iTeos Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- iTeos Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EOS884448 NCT05289492 | Phase 1 | Multiple Myeloma |
| EOS884448 NCT04335253 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow Eos884448 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.